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Abstract
Background: There is evidence that exposure to passive smoking in general, and in babies in particular, is an
important cause of morbimortality. Passive smoking is related to an increased risk of pediatric diseases such as
sudden death syndrome, acute respiratory diseases, worsening of asthma, acute-chronic middle ear disease and
slowing of lung growth.
The objective of this article is to describe the BIBE study protocol. The BIBE study aims to determine the effective-
ness of a brief intervention within the context of Primary Care, directed to mothers and fathers that smoke, in
order to reduce the exposure of babies to passive smoking (ETS).
Methods/Design: Cluster randomized field trial (control and intervention group), multicentric and open. Subject:
Fathers and/or mothers who are smokers and their babies (under 18 months) that attend pediatric services in
Primary Care in Catalonia.
The measurements will be taken at three points in time, in each of the fathers and/or mothers who respond to a
questionnaire regarding their baby’s clinical background and characteristics of the baby’s exposure, together with
variables related to the parents’ tobacco consumption. A hair sample of the baby will be taken at the beginning of
the study and at six months after the initial visit (biological determination of nicotine). The intervention group will
apply a brief intervention in passive smoking after specific training and the control group will apply the habitual
care.
Discussion: Exposure to ETS is an avoidable factor related to infant morbimortality. Interventions to reduce
exposure to ETS in babies are potentially beneficial for their health.
The BIBE study evaluates an intervention to reduce exposure to ETS that takes advantage of pediatric visits. Inter-
ventions in the form of advice, conducted by pediatric professionals, are an excellent opportunity for prevention
and protection of infants against the harmful effects of ETS.
Trial Registration: Clinical Trials.gov Identifier: NCT00788996.
Background
Environmental tobacco smoke (ETS) consists of a mix-
ture of smoke produced by the burning of cigarettes and
the smoke directly exhaled by smokers. A large part of
the smoke that is inhaled by a passive smoker is made by
the burning of cigarettes, which contains certain toxic
components at levels far above those inhaled by the
actual smoker. It has been shown that the levels of
nicotine and tar produced by burning cigarettes are three
times higher than in the smoke directly exhaled by smo-
kers, and the concentration of carbon monoxide (CO)
approximately five times higher [1]. In addition, the spon-
taneous burning of cigarettes produces smaller particles
that are able to penetrate deeper areas of the lungs [2].
Since the milestone publication by Doll and Hill in
1950, it has been known that tobacco is harmful to
health [3], but until 1974 no one had talked about
smoking in fathers/mothers, ETS and the consequences
for children. Currently, we have evidence [4] that the
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effects on infant health: increased risk of sudden infant
death syndrome [5], acute respiratory diseases, respira-
tory symptoms, aggravation of symptoms in patients
with asthma, acute and chronic diseases in the middle
ear and slowed lung growth [6,7]. Passive smoking is the
leading cause of preventable death in infancy in indus-
trialized countries (third cause of preventable death in
adults). According to the International Agency for the
Research on Cancer (IARC) of the World Health Orga-
nization (WHO), second hand smoke is a type A carci-
nogen [8]. Furthermore, the WHO MPOWER report [9]
proposes suggestive evidence between environmental
exposure to tobacco smoke and the following diseases:
leukemia, lymphoma, brain tumors and asthma. It is
particularly worrying in younger children because they
are dependent on adults and therefore cannot avoid
exposure to tobacco smoke; moreover, their immune
systems are underdeveloped.
In Spain, the law on tobacco control measures (28/
2005) has led to notable progress in reducing ETS in
work places and in increasing the awareness of the
damage caused by ETS [10]; however, at the same time
this law has made the home one of the few places
where people can smoke [11]. As an example of the
exceptions and contradictions of the Spanish law, in
“small” places of entertainment (less than 100 square
meters) such as bars and restaurants, the owners can
decide whether or not to apply a smoke-free policy. Pre-
liminary estimates indicate that 90-95% of small estab-
lishments have opted to allow smoking, furthermore,
the Spanish law permits the access of children who go
in the company of their parents [12]. In Catalonia, var-
ious interventions have been carried out to reinforce
smoking cessation during pregnancy [13,14]. ETS has
the greatest effect on the health of children under the
age of five, given that this group of individuals tends to
spend the most time at home, making them the most
vulnerable to the effects of passive smoking [15-17].
There are few studies on measures to reduce ETS in the
home [18]. Various studies have shown that the poten-
tial for tobacco pollution at home is more significant
than levels of atmospheric contamination. Nonetheless,
up to 75% of mothers that smoke expose their newborns
to smoke, and between 47-60% of their babies present
significant levels of urinary cotinine [19,20].
Interventions to reduce passive smoking have obtained
irregular results [21-26]. The Cochrane review [27] on
the subject states that there is no sufficient evidence to
support any one intervention’s effectiveness in reducing
smoking habit in parents and the exposure in children.
Various studies have established that the level of nicotine
in hair is a good quantitative indicator to measure the
environmental exposure of tobacco smoke [28-32].
Health education messages from pediatric profes-
sionals are an excellent opportunity and, in general, are
well accepted by parents since they make reference to
the health of their son or daughter. Brief interventions,
according to the context and impact of the content, can
be just as effective as more intensive interventions [33].
Studies about this type of intervention have not been
published in our country.
It is important to conduct methodologically sound
studies with a more appropriate design (especially in the
calculation of the sample size and monitoring) and eva-
luation through objective measure of results, such as the
level of nicotine in hair.
Objectives
T h ep r i n c i p l eo b j e c t i v eo ft h eB I B Es t u d yi st od e t e r -
mine the effectiveness of a brief intervention directed at
fathers and/or mothers that smoke in order to reduce
ETS in babies, in the context of pediatric visits in pri-
mary care.
The secondary objectives of the BIBE study are
to determine if this intervention produces changes
in the tobacco consumption of the parents and subse-
quently, to study the concordance between the subjec-
tive measures of ETS and the objective measures
(questionnaire versus biological analysis of nicotine in
hair).
The specific objective of this article is to describe the
protocol of the BIBE study.
Methods/Design
Study design
Multi-centric, open cluster randomized field trial. Unit
of randomization: Primary Care teams formed by a
pediatrician and a pediatric nurse, both responsible for
the same infant population.
Setting
Pediatric Primary Care consultations in Catalonia. All of
the basic health areas of Catalonia will be offered parti-
cipation through the xarxa de centres sense fum (net-
work of smoke free centers).
Study period
The preparation and pilot test period: during 2008
Data collection period: March-December 2009. The
period is not coincidental; the first recruitment visit is
in spring and the six-month control visit in the fall, in
order to compare the degree of exposure in a similar cli-
mate period.
Study population
The study subjects are babies under 18 months of age at
the time of recruitment, with a mother and/or father
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sultation (with the doctor or nurse) in Primary Care for
a check-up visit. Figure 1 shows the diagram flow of the
study.
Sampling strategy
During the two-month recruitment period, and until
obtaining the eight proposed cases in each team, all of
the mothers and/or fathers that visit with a baby under
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Figure 1 Flow diagram of the BIBE study. Diagram and flow chart of the BIBE study.
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are smokers.
Inclusion criteria
Babies under 18 months of age whose parents answer
affirmatively to the question “D oy o uo ry o u rp a r t n e r
smoke?” and who give their informed consent to partici-
pate in the study.
Exclusion criteria
- Any pathology or condition that makes inclusion/fol-
l o w - u pd i f f i c u l ta tt h r e ea n ds i x - m o n t h s( a tt h ep r o f e s -
sional’s criteria), for example parent or baby with an
active, acute disease, known addiction in the parents to
other substances or foreseeable change in residency.
- Parent in smoking cessation process at the recruit-
ment phase of the study.
- Refusal of parents to participate in the study.
Sample size
Based on the data from the pilot study in 46 babies and
using the same analysis technique of nicotine in hair
used in the present study, a mean of 6.83 ng/mg and a
standard deviation of 8.88 ng/mg have been obtained.
A s s u m i n gam e a nd i f f e r e n c eo f3 0 %b e t w e e nt h ei n t e r -
vention group and the control group in nicotine in hair
at the end of the intervention, with an alpha value of
0.05 and a power of 80%, 295 subjects are needed in
each group. If we assume a loss of 20%, the sample size
increases to 708 (354 in each group). It is considered
feasible for each basic care unit to recruit eight babies
in a period of two months. The estimates of the intra-
cluster correlation coefficient in cluster randomized
trials that evaluate the implementation of clinical prac-
tice guidelines using outcome variables in primary
healthcare are generally less than 0.05 [34]. These intra-
cluster correlation coefficients translate to a cluster size
of eight in a design effect corresponding to a factor of
1.4. Therefore, the final simple size will be 992 babies
(446 in each group).
Data collection procedures
There will be three visits with each baby included in the
study in both, control and intervention group: a visit at
the start of the study (recruitment) and two follow-up
visits, at three and six months after the recruitment visit
(Figure 1).
T h ef a t h e ra n d / o rm o t h e rw i l lb ea s k e dt op r o v i d e ,
using an electronic data collection system created for
the study, data regarding the following:
1-The baby: age, sex, breastfed/artificial milk, living
nucleus, medical history and clinical data for follow-up,
2- The parents: age, sex, socio-demographic data,
smoking status (yes or no). In smokers, data on the
smoking habit, smoking behavior during pregnancy and
whether or not the baby was breastfed, behavior during
breastfeeding. Finally, smoking behavior changes during
the study.
3-The degree of exposure of the baby to ETS, within
and outside of the home, will be based on the questions
proposed by clinical practice guidelines [13,14,35,36].
In order to measure the levels of biological nicotine in
hair, a sample of the baby’s hair will be taken at the first
(recruitment) visit and at the last (six-month) visit. A
lock of hair will be cut from the root and once col-
lected, will be placed on a card and put into an envel-
ope, which will be provided with the study materials
(Additional files 1 and 2).
For the secondary objective, change in smoking habit
in the father and/or mother, expired carbon monoxide
will be measured in those that declare smoking absti-
nence during the study period. Cut off point: 10 ppm.
Description of laboratory analysis technique
Measuring nicotine in hair provides better information
about average or long-term exposure to ETS as compared
to other biological markers such as cotinine in the urine,
saliva or blood, which have a shorter retrospectivity
[28-32,37]. As hair grows in average at a rate of one cen-
timetre per month, nicotine concentrations found in a
segment of hair are related to the exposure during a per-
iod of time depending on the distance from the root. It is
a specific biological indicator, sensitive, stable over time
and temperature, not influenced by specific exposures
prior to the analysis and easy to obtain [38,39]. The same
IMIM team, with broad experience with the technique,
analyzed all the samples. The analytical procedure of
nicotine in hair utilizes ultra performance liquid chroma-
tography (UPLC) coupled to tandem mass spectrometry
(MS/MS) using a triple quadrupole instrument. The hair
samples (several milligrams) are extensively washed with
dichloromethane to eliminate any superficial contamina-
tion. Then hair samples are dissolved in an alkaline (1 M
potassium hydroxide) solution. The nicotine released
from the matrix of hair is extracted using dichloro-
methane and an aliquot directly analyzed chromatogra-
phically using an HILIC column. Detection by mass
spectrometry: monitoring the transition between the
pseudo molecular ion ([M+H]+ a m/z 163) and the frag-
ment at m/z 117. The procedure uses a deuterated inter-
nal pattern D4-nicotine, which monitors the equal
transition (m/z 167– > 121). The established limit of
quantification is 0.5 ng (nanogram) of nicotine in the
sample (e.g. 0.05 ng/mg in 10 mg simple).
Description of the intervention
Once the teams have shown interest in collaborating in
the study, the participating teams will be randomly
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group, as specified in the methodology.
There will be three visits (at the start of the study, at
three and six months after inclusion in the study for
each baby included in the study (control and interven-
tion group). These visits will be used to collect neces-
sary information.
The teams included in the intervention group will be
given a two-hour specific training on passive smoking,
epidemiology, morbimortality and how to intervene in
the reduction of ETS. The proposed intervention is
based on interventions recommended in primary care
that follow international and national clinical practice
guidelines [13,35,36]. The intervention is based on coun-
seling, cognitive theory and motivational interviewing.
Thus, this study is proposing a passive smoking inter-
vention that has been adapted from an intervention that
has been shown to be effective in decreasing active
tobacco consumption in Primary Care.
The intervention aims to give parents that smoke brief
information that emphasizes the health benefits that
reducing ETS can have on their children. The basic ele-
ments of the intervention include:
1. Ask: whether or not there is a smoker that lives
with the baby. If the answer is affirmative, the baby’s
level of exposure will be asked.
2. Assess knowledge: Information that the parents
have about the effect of passive smoking in infancy.
3. Personalized information depending on the expo-
sure and the perceived risk.
4. Ask about suggestions to make changes: support
any efforts to modify exposure to ETS and discuss the
problems this entails.
5. Personalized help and advice according to exposure,
baby’s background, perceived risk and parents’ attitude
towards making changes. This intervention will be rein-
forced with educational leaflets about passive smoking
in infancy designed for the study (Additional file 3).
6. C o n g r a t u l a t ei ft h em o t h e ra n d / o rf a t h e rh a sq u i t
smoking during the pregnancy and support-encourage
continued smoking cessation.
7. Support and encourage those that decide to quit
smoking or reduce tobacco consumption.
The control group teams will conduct the three pro-
posed visits during the six-month follow-up period.
Aside from collecting the study variables, the control
group will carry out the protocol’sh a b i t u a lc a r ef o ra
healthy child during the corresponding visits. In Catalo-
nia, these visits are officially scheduled and include a
generic reference to avoid exposure to air polluted by
cigarette smoke; however, there is no specific protocol
for action.
Database
The database will be obtained from medical records,
questionnaires (interviews or visits), biological hair sam-
ples from the babies in the first visit and from expired
carbon monoxide (CO) of parents that claim to have
quit smoking.
Follow-up period
The follow-up period is six months from the start of the
intervention.
A visit will be conducted by the pediatrician/nurse at
three and six months after the start of the study. They
will register the parents’ tobacco habit and the level of
ETS exposure obtained by a questionnaire (at three and
six months) and the nicotine in hair (at six months).
Statistical analysis
Statisticians from the University of Girona’sR e s e a r c h
Group in Statistics, Applied Economics and Health
(GRECS) will carry out the statistical analyses. These
statisticians will have an advisory role.
T h ed a t aw i l lb ei n c o r p o r a t e di n t oad a t a b a s ec o n -
structed using SPSS version 15.0. The descriptive ana-
lyses, as well as the statistical hypothesis testing, will
also be conducted with this program. For subsequent
modeling, the Free R software (version 11.0 or later) will
be used.
All of the known potential confounding factors will be
measured at the beginning of the study, including the
caretaker who smokes (and the stage of change), level of
education, marital status, breastfeeding and other mem-
bers of the household, overcrowding. Therefore, the
control and intervention group comparisons will be car-
ried out both adjusted and unadjusted for these known
confounders.
The simple treatment effect without adjusting the
rates, relative risks and the 95% confidence intervals will
be obtained in the first case, with a subsequent adjusted
multiple regression analysis for other variables. Two
forms of regression analysis will be taken into account
for the primaries.
Expected results: A Poisson regression analysis and a
negative binomial if there is evidence of over or under dis-
persion. The analysis of the secondary results will be car-
ried out using standard statistical procedures applicable to
categorical or continuous data. An adjustment for protocol
analysis will also be conducted to verify the robustness of
the results. All tests of significance will be two-tailed. For
the treatment effects, sensitivity analyses will be conducted
to determine the effect of the missing data.
The analysis will be done following the following
study phases:
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Initially an analysis of baseline comparability will be
carried out in relation with the study variables. The
following step will be to estimate the effect on the
response variables without adjusting for other vari-
ables. To perform the above analyses, chi-squared
tests will be used for qualitative variables and com-
parison of means for quantitative variables.
2. To estimate the adjusted effect, a multivariate mul-
tilevel model will be used. The dependent or principal
variable is the child’s exposure using the measure of
nicotine in hair. The baby’s age and sex, as well as the
variables that have been shown to be statistically signifi-
cant, will be included in the bivariate analyses. The
basic care unit and the individual will be the levels in
the multilevel analysis.
3. Concordance between the filled questionnaire and
the nicotine collected in the hair: a summary evaluation
of the questionnaire on a discrete, quantitative scale
based on the data that is provided by the number of
smoking cohabitants, the number of cigarettes that they
smoke and the exposure time outside of the home. Pear-
son’s (or Spearman’s depending on the distribution) cor-
relation coefficient will be calculated between the
estimate and the result obtained in the nicotine hair
analysis. The intraclass correlation coefficient will also
be studied between both measures. Finally, both esti-
mates will be dichotomized (questionnaire and nicotine
in hair analysis) into two categories (exposed/not
exposed) and the Kappa coefficient between the two will
be calculated.
In all cases a bilateral alpha error of 0.05 and a 95%
confidence interval will be used. To complete the expli-
cit information, the comparison of means will be per-
formed using a Student’s t-test for parametric variables
and the U Mann-Whitney test for non-parametric
variables.
Results
Primary results to obtain:
Reduction of exposure to ETS measured at the begin-
ning of the intervention (recruitment phase) and at six
months, using a questionnaire that includes information
about ETS history during pregnancy and breastfeeding,
exposure to ETS within and outside of the home, family
smoking habits and measures used to avoid exposure.
To develop this questionnaire, questionnaires used in
similar studies have been adapted (varying some items,
based on the results of the pilot study). As an objective
measurement of the exposure: biological levels of nico-
tine in hair of babies. All of the hair samples (from the
pilot test and the definitive study) will be analyzed by
the same team at IMIM.
Secondary results to obtain:
- Reduction or cessation of smoking habit in parents,
measured using a questionnaire about status of the smo-
ker/ex-smoker/non-smoker and using the Fagerström
Nicotine Dependence Test in those that smoke, as well
as the stage of change (pre-contemplation, contempla-
tion, preparation, action, maintenance, finalization). In
smokers that declare smoking abstinence, the amount of
carbon monoxide in expired air will be determined
(Smokerlyzer). Cut-off point: 10 ppm.
-Other variables using questionnaire/clinical records,
including data related to:
Type of professional that performs the intervention:
pediatrician, pediatric nurse or both.
The baby: age, sex, breastfeeding, medical history, liv-
ing nucleus.
The father and/or mother that attends the visit: age,
sex, marital status, socioeconomic situation.
Parents’ level of knowledge and their level of risk per-
ception to exposure.
Quality control
Several procedures have been employed to ensure the
quality of the study data, maximizing the validity and
reliability of the data obtained and of the evaluation of
the results: These are:
-Written documentation: electronic and printed copies
of protocols, models and outlines of informed consent
stored together. All written documentation, including
the leaflets given to participants, have been created
according to a standard model and have been subject to
the approval of local institutional ethics committees.
-A pilot study has been conducted to reveal deficien-
cies in the study design.
-An informational meeting will be held for both the
intervention and control group to distribute documenta-
tion and to explain and materials.
-Learning: All of the intervention group professionals
will receive the same two-hour workshop on passive
smoking, attributable morbimortality and how to reduce
exposure to ETS.
-Meetings will be held and regular emails will be sent
regularly between the members that lead the study and
all of the participants from the centers.
Ethical aspects
The study and its successive revisions are adapted to the
criteria of the Helsinki Declaration, as well as to the
Guidelines to Good Clinical Practice. The protocol has
been reviewed and approved by the CEIC” Clinical
Research Ethics Committee” of the Jordi Gol and Gurina
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Page 6 of 10Foundation for the Promotion of Research in Primary
Care (IDIAP Jordi Gol), with the number P08/50 “BIBE”.
In regards to parents’ informed consent, the informa-
tion is provided verbally and written to all participants.
Individuals in the study will have the opportunity to
resolve doubts about study details. The written consent
states that the study follows the law contained in the
Helsinki Declaration and in Title I, Article 12 of the
Royal Spanish Decree 561/1993 from April 16
th, 1993.
Data confidentiality: Participants will be informed that
data will be treated with absolute confidentiality accord-
ing to the organic law that regulates the confidentiality of
computerized data (Organic law 5/1992), and that data
will be used exclusively for the objectives of the study.
Voluntary withdrawal: A mo t h e ro rf a t h e rc a nv o l u n -
tarily withdraw his or her baby from the project at any
point without having to give an explanation. He or she
also has the right to ask that their personal data be
eliminated from the records at any point, as well as for
the results of their interviews.
Limitations
The following limitations have been taken into
consideration:
Professionals, rather than subjects (babies) will be ran-
domized. Although this reduces the variability of the
sample studied, it is necessary in order to minimize the
possibility of contamination between groups.
T h ei n t e r v e n t i o nw i l lb ec a r r i e do u to n l yi np a r e n t s
that visit the centers that are being studied, thus exclud-
ing a group of people that use other care services or
that do not attend scheduled appointments. This phe-
nomenon is present in normal clinical conditions, and
the research team wants to show utility and feasibility in
normal conditions, such as the ones taken into consid-
eration in this design.
There could be a contamination effect in the control
group due to the pre-test and the feeling of being
observed during the study.
Intervention to prevent exposure to ETS will be carried
out on the person who attends to the primary care con-
sultation, therefore it can influence smoking status or
not. For instance, the response to the intervention to pre-
vent ETS exposure to babies could be greater or lesser
according to the smoking status of the person. To esti-
mate the possible effect of this phenomenon we will col-
lect the status of tobacco consumption of the caretaker
as well as of the other persons living with the child.
Discussion
Exposure to ETS is an avoidable factor related to infant
morbimortality. Interventions to reduce exposure to
ETS in babies are potentially beneficial for their health.
As discussed in the introduction, increased exposure is
declared in places not included in the Spanish tobacco
law 28/2005. This justifies the need to define and pro-
mote a pediatric program in Primary Care that includes
awareness interventions in t h ef a m i l ye n v i r o n m e n t ,i n
places not included in the law (bars and cafes) or places
that cannot be regulated because they belong to the pri-
vate sphere (homes and cars), in order to achieve pro-
cesses of change and protect infants.
The BIBE study evaluates, in real conditions, an
intervention to reduce exposure to ETS that takes
advantage of pediatric visits. The intervention that is
proposed in the BIBE study aims to impact the attitude
and knowledge of parents regarding ETS. Interventions
in the form of advice, conducted by pediatric profes-
sionals, are an excellent opportunity for prevention and
protection of infants against the harmful effects of
ETS. In our country, health centers have almost uni-
versal coverage, including all social classes and situa-
t i o n s .I nf a c t ,i ft h es t u d yp r o v e st ob ee f f e c t i v ei t
would also be efficient, since the intervention uses the
same professionals that are responsible for the routine
care of newborns.
Based on the bibliography, more research in passive
smoking that uses objective measures of evaluation is
necessary. Such research will generate evidence on the
information that we are interested in collecting in order
to learn children’s exposure to cigarette smoke. It will
also help to identify which intervention is effective in
reducing this exposure. This is what we aim to do in
the BIBE study.
Additional material
Additional file 1: Image 1. Cut a lock of the hair. Images showing
how to cut a lock of baby’s hair.
Additional file 2: Image 2. Sample of the baby’s hair to label and
send. Image of a sample of baby’s hair that was used to analyze nicotine
concentration.
Additional file 3: Image 3. Leaflet: Passive smoking: advice to
decrease exposure in babies. Image showing a leaflet in Catalan which
contains correct and incorrect advices for parents to reduce baby’s
exposure to environmental tobacco smoke.
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